COMPARATIVE STUDY OF SQUASH CYTOLOGY AND HISTOPATHOLOGY IN GLIOBLASTOMA AND ITS VARIANTS

Author:

Patil Priyanka1,Mokhashi Rohini2,Pathan Tabassumnaz3

Affiliation:

1. Assistant Professor, Department of Pathology, Mahadevappa Rampure Medical College. Kalaburagi. Karnataka state.

2. Post graduate trainee, Department of Pathology. Mahadevappa Rampure Medical College. Kalaburagi. Karnataka State.

3. Post graduate trainee. Department of Pathology. Mahadevappa Rampure Medical college. Kalaburagi. Karnataka state.

Abstract

Introduction Glioblastoma is the most aggressive and deadly of all brain tumors. It accounts for 12-15% of all intracranial neoplasm and 50-60% (1) of all astrocytic tumours Even though Glioblastoma is a quite rare tumor with a global incidence rate of less than 10 per 100,000 it signicantly (2) impacts the life of the affected patients due to its poor prognosis with a median survival time of only 14-15 months from the time of diagnosis . Materials And MethodsA total of 21 cases of Glioblastomas were studied over a period of 5yrs from 2017 to 2022. Intraoperative squash smears were prepared, stained with toluidine blue, “Hematoxylin and Eosin” and examined. The residual tissue samples were processed for parafn section and stained by Hematoxylin and Eosin and IHC was done wherever necessary. Histopathological examination was carried out for conrmative diagnosis and squash smear cytology diagnoses were correlated with nal histopathological ndings. Out of 21 cases, 12 Results were Glioblastoma, 7 were Gliosarcoma, one each of Epithelioid Glioblastoma and Gemistocytic Glioblastoma. Male to Female Ratio is 2.5:1. Most common clinical presentations were Headache, giddiness, vomiting and weakness/paresis in lower limbs. Intraoperative Squash smear cytology could diagnose high grade gliomas with 100 % accuracy which was concordant with histopathological diagnosis. Squash Conclusion smear cytology ndings, if interpreted with clinical picture and radio-imaging ndings, will help to reach an accurate and rapid diagnosis of intracranial tumor, but histopathology remains gold standard for conrmation of diagnosis and differentiating the variants.

Publisher

World Wide Journals

Subject

Mechanical Engineering,Mechanics of Materials,Biomedical Engineering,Medicine (miscellaneous),Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,General Medicine,General Immunology and Microbiology,Endocrine and Autonomic Systems,Endocrinology, Diabetes and Metabolism,Pharmacology (medical),Psychiatry and Mental health,Pharmacology,General Nursing,Food Science,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference17 articles.

1. Khanna M, Mandritta P and Roy S: Clinicopathological study of 115 cases of Glioblastoma multiforme with special reference to Gliosarcoma – An original research article. Int J Pharm Sci Res 2013; 4(6); 2384-2392.

2. Farina Hanif, Kanza Muzaffar, Kashkashian Parveen, Saima M Malhi and Shabana U Simjee. Glioblastoma Multiforme: A Review of its Epidemiology and Pathogenesis through clinical presentation and Treatment: Asian Pac J Cancer Prev. 2017;18(1):3-9.

3. David N. Louis, Arie Perry, Pieter Wesseling, Daniel J. Brat, Ian A. Cree, Dominique Figarella-Branger, Cynthia Hawkins, H. K. Ng, Stefan M. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary: Neuro-Oncology 23(8), 1231–1251, 2021.

4. Greenfield’s Neuropathology 9th Edition: vol-I:1650-1659.

5. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al. European Organization for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. NEngl J Med. 2005 Mar 10;352(10):987-96.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3